Ascendis Pharma to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

10 months ago

COPENHAGEN, Denmark, June 07, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President &…

Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer

10 months ago

Bill Little, previously Chief Operating Officer (COO) of Neovasc, Inc. through its acquisition by Shockwave Medical in April 2023, will…

Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific Sessions

10 months ago

SAN FRANCISCO and SHANGHAI, China, June 07, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical…

Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares

10 months ago

COPENHAGEN, Denmark, June 07, 2023 (GLOBE NEWSWIRE) -- Forward Pharma A/S (OTC:FWPAY) (“Forward” or the “Company”) today announced that its…

ODAIA Adds Demonstrated Industry Talent Following Successful Series B

10 months ago

Rebecca Skvorc named Chief Financial OfficerJim Diefenbach named SVP of SalesMike Goulart named Sr. Director, Business AccelerationTORONTO, June 06, 2023…

Lucy Scientific Discovery to Present at the LD Micro Invitational XIII Conference on June 7

10 months ago

VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a leader in natural and…

22nd Century Group (XXII) Launching VLN® at #1 U.S. C-Store Chain in Texas, California and Florida

10 months ago

Largest U.S. C-Store Chain Will Add VLN® to More Than 1,450 Corporate Stores in Three Largest State Markets, Incentivizes Additional…

Baudax Bio Announces Date of Reconvened Annual Meeting

10 months ago

Annual Meeting to be reconvened on June 23, 2023MALVERN, Pa., June 06, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX)…

Carmot Therapeutics Appoints Michael Gray as Chief Financial Officer and Chief Operating Officer

10 months ago

Gray brings significant biotech financial and operations experience to Carmot to advance a clinical pipeline of therapies to treat people…

Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement

10 months ago

Company continuing to prepare for advancement of clinical assets, including ELX-02 pivotal study in Alport Syndrome and ZKN-013 Phase 1…